Float Short %

25.16

Margin Of Safety %

Put/Call OI Ratio

0.61

EPS Next Q Diff

1.03

EPS Last/This Y

1.72

EPS This/Next Y

-0.16

Price

Target Price

16.14

Analyst Recom

2.14

Performance Q

-29.66

Relative Volume

1.03

Beta

3.13

Ticker: NVAX

22 items of 1

Date	Symbol	Last	P/C OI	P/C Vol	Total OI
2025-03-20	NVAX	7.72	0.61	0.12	247924
2025-03-21	NVAX	7.61	0.61	0.33	249339
2025-03-24	NVAX	7.68	0.62	0.23	234680
2025-03-25	NVAX	7.57	0.61	0.10	242635
2025-03-26	NVAX	7.39	0.60	0.20	244445
2025-03-27	NVAX	7.25	0.59	0.86	247289
2025-03-28	NVAX	7	0.58	0.37	248319
2025-03-31	NVAX	6.41	0.59	0.37	241908
2025-04-01	NVAX	6	0.59	0.52	250289
2025-04-02	NVAX	5.98	0.58	1.52	257593
2025-04-03	NVAX	5.59	0.60	0.48	263661
2025-04-04	NVAX	6.23	0.58	0.29	267199
2025-04-07	NVAX	6.54	0.59	0.23	264074
2025-04-08	NVAX	6.32	0.60	0.13	266286
2025-04-09	NVAX	6.76	0.59	0.07	269351
2025-04-10	NVAX	5.43	0.59	0.25	270274
2025-04-11	NVAX	5.84	0.57	0.30	276599
2025-04-14	NVAX	6.41	0.57	0.07	264064
2025-04-15	NVAX	6.39	0.56	0.25	267328
2025-04-16	NVAX	6.2	0.56	1.90	269234
2025-04-17	NVAX	6.01	0.61	2.19	287934
2025-04-18	NVAX	6	0.61	1.89	287934
Date	Symbol	Last	P/C OI	P/C Vol	Total OI

22 items 1 of 1

22 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-03-20	NVAX	7.72	50.5	-	-0.24
2025-03-21	NVAX	7.61	50.5	-	-0.24
2025-03-24	NVAX	7.69	50.5	-	-0.24
2025-03-25	NVAX	7.56	50.5	-	-0.24
2025-03-26	NVAX	7.39	50.5	-	-0.24
2025-03-27	NVAX	7.26	50.5	-	-0.24
2025-03-28	NVAX	7.00	50.5	-	-0.24
2025-03-31	NVAX	6.41	50.5	-	-0.24
2025-04-01	NVAX	6.00	50.5	-	-0.24
2025-04-02	NVAX	5.98	50.5	-	-0.24
2025-04-03	NVAX	5.60	50.5	-	-0.24
2025-04-04	NVAX	6.24	50.5	-	-0.24
2025-04-07	NVAX	6.53	151.8	-	0.27
2025-04-08	NVAX	6.31	151.8	-	0.27
2025-04-09	NVAX	6.75	151.8	-	0.27
2025-04-10	NVAX	5.43	151.8	-	0.27
2025-04-11	NVAX	5.86	151.8	-	0.27
2025-04-14	NVAX	6.41	151.8	-	0.27
2025-04-15	NVAX	6.39	151.8	-	0.27
2025-04-16	NVAX	6.21	151.8	-	0.27
2025-04-17	NVAX	6.00	151.8	-	0.27
2025-04-18	NVAX	6.00	151.8	-	0.49
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

22 items 1 of 1

22 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-03-20	NVAX	-0.10	1.97	26.76
2025-03-21	NVAX	-0.10	1.97	26.76
2025-03-24	NVAX	-0.10	1.96	26.76
2025-03-25	NVAX	-0.10	1.96	26.76
2025-03-26	NVAX	-0.10	1.96	25.62
2025-03-27	NVAX	-0.10	1.96	25.62
2025-03-28	NVAX	-0.10	1.96	25.62
2025-03-31	NVAX	-0.10	1.96	25.62
2025-04-01	NVAX	-0.10	1.96	25.62
2025-04-02	NVAX	-0.10	1.96	25.62
2025-04-03	NVAX	-0.10	1.96	25.62
2025-04-04	NVAX	-0.10	1.96	25.62
2025-04-07	NVAX	-0.10	1.96	25.62
2025-04-08	NVAX	-0.10	1.96	25.62
2025-04-09	NVAX	-0.10	1.96	25.62
2025-04-10	NVAX	-0.10	1.96	25.16
2025-04-11	NVAX	-0.10	1.96	25.16
2025-04-14	NVAX	-0.10	1.96	25.16
2025-04-15	NVAX	-0.10	1.96	25.16
2025-04-16	NVAX	-0.10	1.96	25.16
2025-04-17	NVAX	-0.10	1.96	25.16
2025-04-18	NVAX	-0.10	1.96	25.16
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

22 items 1 of 1

Last Quarter Act. EPS

-0.83

Avg. EPS Est. Current Quarter

-0.42

Avg. EPS Est. Next Quarter

0.2

Insider Transactions

-0.1

Institutional Transactions

1.96

Beta

3.13

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

155

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

98.2

Max Drawdown 5-Year %

-98.8

Target Price

16.14

P/E

Forward P/E

17.14

PEG

P/S

1.41

P/B

P/Free Cash Flow

EPS

-1.32

Average EPS Est. Cur. Y

0.49

EPS Next Y. (Est.)

0.33

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-27.49

Relative Volume

1.03

Return on Equity vs Sector %

10.1

Return on Equity vs Industry %

23.5

EPS 1 7Days Diff

0.7

EPS 1 30Days Diff

0.74

EBIT Estimation

Novavax, Inc.

Sector: Healthcare

Industry: Biotechnology

Employees: 952

Novavax, Inc., a biotechnology company, engages in the discovering, developing, and commercializing vaccines to protect against serious infectious diseases in the United States, Europe, and internationally. The company offers vaccine platform that combines a recombinant protein approach, nanoparticle technology, and its patented Matrix-M adjuvant to enhance the immune response. The company is commercializing a COVID-19 vaccine, NVX-CoV2373 under the brand names of Nuvaxovid, Covovax, and Novavax COVID-19 Vaccine, adjuvanted for adult and adolescent populations as a primary series and for both homologous and heterologous booster indications. It also developing R21/Matrix-M adjuvant malaria vaccine. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.

stock quote shares NVAX – Novavax, Inc. Stock Price stock today

news today NVAX – Novavax, Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch NVAX – Novavax, Inc. yahoo finance google finance

stock history NVAX – Novavax, Inc. invest stock market

stock prices NVAX premarket after hours

ticker NVAX fair value insiders trading

Investment involves risk. As a general rule, you should only trade in financial products that you are familiar with and understand the risk associated with them. The risk warning described in each financial product below is not exhaustive, you should carefully consider your investment experience, financial situation, investment objective, risk tolerance level and consult your independent financial adviser as to the suitability of your situation prior making any investment.

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: NVAX

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Get Started

About

Last Quarter Act. EPS

Average EPS Est. Cur. Y